Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Nishio Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit, indicating a concentrated prosecution effort for the company's current filings. The focus on a single examiner suggests that the company's pharmaceutical or biotechnological research is currently being evaluated through a single point of contact at the patent office.
The busiest examiner identified is HELM, CARALYNNE E, who is currently handling 1 pending office action. Because the total pending office actions for the company is 1, this examiner manages the entirety of the active workload. This distribution means that the company's immediate prosecution outcomes in the Biotechnology & Pharmaceuticals sector are tied directly to the feedback and examination style of HELM, CARALYNNE E.
Practitioners should note that having 1 distinct art unit and 1 distinct examiner for the 1 pending office action simplifies the administrative process. There are no competing priorities or different examination standards to balance across the portfolio. This focused profile allows the applicant to dedicate all resources to addressing the specific issues raised in the single pending office action within the assigned art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELM, CARALYNNE E | 1 | 28.9% | +49.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700823 | Tooth Surface Treating Agent and Tooth Surface Treating Kit | HELM, CARALYNNE E | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700823 | Tooth Surface Treating Agent and Tooth Surface Treating Kit | HELM, CARALYNNE E | 14d |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18700823 | Tooth Surface Treating Agent and Tooth Surface Treating Kit | HELM, CARALYNNE E | 1615 | §102§103§112 | Final Rejection | 14d | Pending | Apr 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial